| Biological Sciences | Lifetime | 489 | IT 7 | 99.94 |
| Microbiology | Lifetime | 6 | IT 1 | 99.89 |
| Epidemiology | Lifetime | 263 | IT 10 | 99.67 |
| Infectious Diseases | Lifetime | 116 | IT 6 | 99.64 |
| Immunology | Lifetime | 295 | IT 10 | 99.28 |
| Endocrinology | Lifetime | 84 | IT 1 | 98.80 |
| Health | Lifetime | 230 | IT 1 | 98.57 |
| Infectious Diseases | 2021-2025 | 82 | IT 11 | 98.77 |
| Microbiology | 2021-2025 | 129 | IT 4 | 74.22 |
| Bacterial Infections and Vaccines | Lifetime | 1 | IT 1 | 99.96 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 10 | IT 1 | 99.90 |
| vaccines and immunoinformatics approaches | Lifetime | 3 | IT 1 | 99.87 |
| Galectins and Cancer Biology | Lifetime | 13 | IT 1 | 99.62 |
| Pneumonia and Respiratory Infections | Lifetime | 21 | IT 2 | 99.82 |
| Toxin Mechanisms and Immunotoxins | Lifetime | 13 | IT 1 | 99.67 |
| Vaccine Coverage and Hesitancy | Lifetime | 15 | IT 1 | 99.70 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 40 | IT 4 | 99.66 |
| Influenza Virus Research Studies | Lifetime | 35 | IT 1 | 99.75 |
| Escherichia coli research studies | Lifetime | 24 | IT 1 | 99.61 |
| Veterinary medicine and infectious diseases | Lifetime | 12 | IT 1 | 99.62 |
| Viral gastroenteritis research and epidemiology | Lifetime | 88 | IT 2 | 99.59 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 656 | IT 16 | 98.91 |
| Immune Response and Inflammation | Lifetime | 412 | IT 13 | 98.95 |
| Virology and Viral Diseases | Lifetime | 157 | IT 2 | 98.32 |
| Immune responses and vaccinations | Lifetime | 46 | IT 1 | 97.82 |
| Bacteriophages and microbial interactions | Lifetime | 466 | IT 3 | 98.44 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 198 | IT 7 | 98.28 |
| Respiratory viral infections research | Lifetime | 428 | IT 8 | 98.37 |
| Immunotherapy and Immune Responses | Lifetime | 908 | IT 26 | 98.61 |
| Diphtheria, Corynebacterium, and Tetanus | Lifetime | 45 | IT 1 | 96.81 |
| RNA and protein synthesis mechanisms | Lifetime | 897 | IT 14 | 98.29 |
| Transgenic Plants and Applications | Lifetime | 183 | IT 2 | 97.49 |
| Bacterial Genetics and Biotechnology | Lifetime | 508 | IT 3 | 98.10 |
| Viral Infections and Outbreaks Research | Lifetime | 271 | IT 3 | 97.43 |
| Streptococcal Infections and Treatments | Lifetime | 886 | IT 20 | 95.91 |
| Neonatal and Maternal Infections | Lifetime | 349 | IT 15 | 94.93 |
| Vibrio bacteria research studies | Lifetime | 881 | IT 8 | 94.71 |
| Biochemical and Structural Characterization | Lifetime | 704 | IT 21 | 92.74 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 192 | IT 6 | 99.11 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 61 | IT 4 | 97.90 |
| COVID-19 Clinical Research Studies | 2021-2025 | 790 | IT 83 | 96.72 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 440 | IT 27 | 94.43 |
| vaccines and immunoinformatics approaches | 2021-2025 | 168 | IT 5 | 91.68 |
| Immunotherapy and Immune Responses | 2021-2025 | 889 | IT 17 | 91.41 |
| Pneumonia and Respiratory Infections | 2021-2025 | 795 | IT 61 | 88.06 |
| Bacterial Infections and Vaccines | 2021-2025 | 322 | IT 9 | 85.20 |
| Escherichia coli research studies | 2021-2025 | 377 | IT 10 | 78.74 |
